New Asthma Drug Generates Excitement For Patients — And Its Maker – Forbes

New Asthma Drug Generates Excitement For Patients — And Its Maker
Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough and give yet another boost to Regeneron Pharmaceuticals, the company developing it, which has seen its shares rise 376% in the past two years,
Regeneron, Sanofi asthma drug seen as potential game changerReuters
Monoclonal antibody appears effective and safe in asthma Phase IIa trialScience Codex
Sanofi, Regeneron Report Publication Of Phase 2a Results Of Dupilumab In RTT News
MarketWatch (press release)
all 5 news articles »

View full post on asthma – Google News

Obamacare Spurs New Thinking On Using the Market to Pay for Prevention – Forbes


India Today

Obamacare Spurs New Thinking On Using the Market to Pay for Prevention
Forbes
And it also is ranked as the second-most polluted city in the country. One result: 17.3 percent of Fresno residents have asthma, more than twice the national average. Every day, 20 asthma sufferers go to the emergency department and three are hospitalized.
Cost, accessibility of health reform act questionedNew Philadelphia Times Reporter

all 575 news articles »

View full post on asthma – Google News

The Worst Cities For Allergies In 2012 – Forbes


WRAL.com

The Worst Cities For Allergies In 2012
Forbes
For the tenth consecutive year, non-profit patient organization the Asthma and Allergy Foundation of America (AAFA) has released its list of the worst cities for allergies in the nation. Researchers analyzed the 100 largest metro areas in the US by
Free Asthma and Allergy Screenings Offered Nationwide New Tools Help More Newswise (press release)
Springtime allergies can trigger asthma attacks in childrenWRAL.com
Health topics: Traveling With Allergies and AsthmaNewsolio (blog)
Lexington Herald Leader
all 9 news articles »

View full post on asthma – Google News

Study Highlights Hidden Dangers in Everyday Products – Forbes


Forbes

Study Highlights Hidden Dangers in Everyday Products
Forbes
The study was funded by Silent Spring Institute, which had 213 consumer products (in 50 categories) independently tested by Battelle Labs in Ohio for 66 specific chemicals associated with either endocrine disruption or asthma.
Silent Spring Seeks to Stoke Consumer Fears Without Regard For the FactsMarketWatch (press release)

all 4 news articles »

View full post on asthma – Google News

Goldman Sachs downgrades Glaxo to “sell” – Forbes

Goldman Sachs downgrades Glaxo to "sell"
Forbes
AP , 05.31.11, 10:57 AM EDT WASHINGTON — A Goldman Sacks analyst says GlaxoSmithKline's stock is overvalued as the British drugmaker prepares to face lower sales of its best-selling product, the asthma inhaler Advair. Goldman analyst Mark Beards notes
Goldman Downgrades GSK as Growth Won't Support ValuationBarron’s (blog)
Goldman Sachs downgrades Glaxo to "sell"CBS MoneyWatch.com

all 10 news articles »

View full post on asthma – Google News

Peabody Punked by Fake ‘Coal Cares’ Asthma Site – Forbes (blog)


Treehugger

Peabody Punked by Fake 'Coal Cares' Asthma Site
Forbes (blog)
Peabody Energy, the world's largest coal company, is not, repeat, NOT, giving kids free asthma inhalers decorated with pictures of Justin Beiber, My Little Pony or Miley Cyrus. The Coal Cares™ Website unveiled today,
Coal Cares Site, A Brilliant Hoax of The Coal IndustryFast Company
Peabody Energy Says It's Victim Of Website HoaxWall Street Journal
Asthma Medication! Free Inhalers! Big Coal Really CaresRollingStone.com (blog)
GPB –Minyanville.com –Daily Press (blog)
all 18 news articles »

View full post on asthma – Google News